Adulterants Testing

Kratom Adulterants

The Kratom Adulterants panel quantitatively reports six named targets associated with emerging kratom-market formulations and adulterant-screening questions.

Share the exact product, matrix, reporting objective, target market, and deadline. The laboratory confirms method-and-matrix fit, sample requirements, reporting basis, timing, and price during technical review.

Request This Panel View Adulterants Testing

For quote and submission reference: Test Code T191.

Quantitative Coverage

Six individually reported targets

Every analyte below is quantitatively reported. No broader class total is implied by this list.

017-Hydroxymitragynine
02Mitragynine pseudoindoxyl
039-Hydroxycorynantheidine
04Dihydro-7-hydroxymitragynine (MGM-15)
059-Fluoro-dihydro-7-hydroxymitragynine (MGM-16)
067-Acetoxymitragynine

Why This Is Separate

Composition and adulterant targets are different scopes

The general Mitragyna Alkaloids profiles are intended for botanical potency and composition. The Kratom Adulterants panel keeps mitragynine pseudoindoxyl and other emerging derivative or adulterant targets in a separate analytical scope.

Each of the six listed targets is quantitatively reported. The panel does not establish botanical identity, determine whether a product is safe, provide legal advice, or certify regulatory compliance.

Compare the 5- and 11-analyte Mitragyna profiles

Time-Sensitive Regulatory Context

DEA notices of intent

On July 6, 2026, DEA published a notice of intent to temporarily place mitragynine pseudoindoxyl, dihydro-7-hydroxymitragynine (MGM-15), and 9-fluoro-dihydro-7-hydroxymitragynine (MGM-16) in Schedule I. The notice states that controls would begin only if and when a temporary scheduling order is published.

DEA published a separate notice of intent concerning 7-hydroxymitragynine above a specified threshold. 9-Hydroxycorynantheidine and 7-acetoxymitragynine are analytical targets in this panel but are not identified in either of those two cited notices.

Regulatory status can change quickly. Verify current DEA and Federal Register records and obtain appropriate legal or regulatory guidance before relying on this summary. Cora Science provides analytical results and does not certify product compliance.

Status reviewed August 8, 2026.

Primary sources

Technical Review

Operating details are confirmed for the submitted project

The public panel scope confirms the six quantitative targets. Method, matrix eligibility, sample quantity, reporting units, sensitivity, turnaround, accreditation applicability, and price are confirmed during technical review rather than assumed from another botanical method.

Exact product and matrix
Testing objective or customer-defined specification
Target market or jurisdiction
Requested reporting basis or units
Required sensitivity or reporting limits
Sample count and requested deadline

FAQ

Planning a submission

Is this the same as the 11-analyte Mitragyna profile?

No. The 11-analyte profile is a general botanical potency and composition panel. Kratom Adulterants is a separate six-analyte testing scope that includes mitragynine pseudoindoxyl.

Does ordering this panel establish regulatory compliance?

No. The panel supplies quantitative analytical results for the six listed targets. It does not provide legal advice, determine safe use, or certify that a product complies with any jurisdiction's current requirements.

What sample quantity, reporting units, and turnaround apply?

Those operating details depend on the submitted matrix and project requirements and are confirmed during technical review before testing begins.

Next Step

Request this panel and share the exact product and reporting question.

Request This Panel Contact the Lab